Methyl aminolevulinate
- Generic Name
- Methyl aminolevulinate
- Brand Names
- Metvix, Metvixia
- Drug Type
- Small Molecule
- Chemical Formula
- C6H11NO3
- CAS Number
- 33320-16-0
- Unique Ingredient Identifier
- 585NM85KYM
Overview
Methyl aminolevulinate is a prodrug that is metabolised to Protoporphyrin IX (a photosensitizer) used in photodynamic therapy.
Background
Methyl aminolevulinate is a prodrug that is metabolised to Protoporphyrin IX (a photosensitizer) used in photodynamic therapy.
Indication
For topical use, in combination with 570 to 670 nm wavelength red light illumination, in the treatment of non-hyperkeratotic actinic keratoses of the face and scalp in immunocompetent patients when used in conjunction with lesion preparation (debridement using a sharp dermal curette).
Associated Conditions
- Actinic Keratosis of Face and Scalp
Clinical Trials
FDA Approved Products
No FDA products found for this drug
Singapore Approved Products
No Singapore products found for this drug
Drug Development Updates
Stay informed with timely notifications on clinical trials and research advancements.
© Copyright 2025. All Rights Reserved by MedPath